(Q35559869)

8 August 2017

1 reference

title

Renal cell carcinoma: relevance of pathology (English)

1 reference

8 August 2017

Mototsugu Oya

1

1 reference

8 August 2017

Masaru Murai

2

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14560136

21 March 2024

publication date

1 November 2003

1 reference

full work available at URL

8 August 2017

https://journals.lww.com/00042307-200311000-00004

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Current Opinion in Urology

21 March 2024

published in

1 reference

8 August 2017

volume

13

1 reference

8 August 2017

issue

6

1 reference

8 August 2017

page(s)

445-449

1 reference

Spindle and cuboidal renal cell carcinoma, a tumour having frequent association with nephrolithiasis: report of 11 cases including a case with hybrid conventional renal cell carcinoma/ spindle and cuboidal renal cell carcinoma components

8 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Renal cell carcinoma with rhabdoid features: an aggressive neoplasm

21 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Multilocular cystic renal cell carcinoma: a series of 12 cases and review of the literature

21 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients

21 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Prognostic significance of nuclear morphometry in renal cell carcinoma

21 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Contribution of grade, vascular invasion and age to outcome in clinically localized renal cell carcinoma

21 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Metastatic renal carcinoma comprehensive prognostic system

21 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology

21 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma

21 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Expression of CD154 on renal cell carcinomas and effect on cell proliferation, motility and platelet-activating factor synthesis

21 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Expression of cadherin-8 in renal cell carcinoma and fetal kidney

21 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Expression of the free beta-subunit of human chorionic gonadotropin in renal cell carcinoma: prognostic study on tissue and serum.

21 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Proline oxidase induces apoptosis in tumor cells, and its expression is frequently absent or reduced in renal carcinomas

21 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Loss of tumor suppressor protein PTEN during renal carcinogenesis.

21 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma

21 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma

21 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma.

21 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome

21 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas

21 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Cyclin E and p27 protein content in human renal cell carcinoma: clinical outcome and associations with cyclin D

21 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Cyclin D3 protein content in human renal cell carcinoma in relation to cyclin D1 and clinico-pathological parameters

21 March 2024

25

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas

21 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron

21 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma

21 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel-Lindau gene and hypoxia.

21 March 2024

31

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma.

21 March 2024

32

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein

21 March 2024

33

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma

21 March 2024

34

1 reference

https://api.crossref.org/works/10.1097/00042307-200311000-00004

21 March 2024

Identifiers

1 reference

8 August 2017

1 reference